Significant Ownership of Medtronic plc
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Medtronic plc focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Brian Sandstrom - Brian Sandstrom/VP, Chief Corporate and Securities Counsel
- Manager location
- Galway
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Medtronic plc and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from Medtronic plc
Significant Ownership of Medtronic plc
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| MMED | MiniMed Group, Inc. | Common Stock, par value $0.01 per share | 90% | $3,637,984,078 | 252,813,348 | Medtronic plc | 31 Mar 2026 | ||
| OBIO | Orchestra BioMed Holdings, Inc. | Common Stock, Par Value $0.0001 Per Share | 18% | $41,826,294 | +$17,470,292 | 10,078,625 | +72% | Medtronic plc | 31 Dec 2025 |
| AVR | Anteris Technologies Global Corp. | Common Stock | 16% | $78,107,474 | 15,652,173 | Medtronic plc | 22 Jan 2026 |
Schedules 13D/G Reported by Medtronic plc:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.